AU2003278165A1 - Diagnostics and therapeutics for diseases associated with human endothelial differentiation, lysophosphatidic acid g-protein-coupled receptor 2 (edg2) - Google Patents
Diagnostics and therapeutics for diseases associated with human endothelial differentiation, lysophosphatidic acid g-protein-coupled receptor 2 (edg2)Info
- Publication number
- AU2003278165A1 AU2003278165A1 AU2003278165A AU2003278165A AU2003278165A1 AU 2003278165 A1 AU2003278165 A1 AU 2003278165A1 AU 2003278165 A AU2003278165 A AU 2003278165A AU 2003278165 A AU2003278165 A AU 2003278165A AU 2003278165 A1 AU2003278165 A1 AU 2003278165A1
- Authority
- AU
- Australia
- Prior art keywords
- edg2
- therapeutics
- diagnostics
- protein
- diseases associated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 title 1
- 102100031174 C-C chemokine receptor type 10 Human genes 0.000 title 1
- 108010088144 CCR10 Receptors Proteins 0.000 title 1
- 101000966782 Homo sapiens Lysophosphatidic acid receptor 1 Proteins 0.000 title 1
- 102100040607 Lysophosphatidic acid receptor 1 Human genes 0.000 title 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000009762 endothelial cell differentiation Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02025100 | 2002-11-13 | ||
| EP02025100.5 | 2002-11-13 | ||
| PCT/EP2003/012121 WO2004044580A1 (en) | 2002-11-13 | 2003-10-31 | Diagnostics and therapeutics for diseases associated with human endothelial differentiation, lysophosphatidic acid g-protein-coupled receptor 2 (edg2) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003278165A1 true AU2003278165A1 (en) | 2004-06-03 |
Family
ID=32309329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003278165A Abandoned AU2003278165A1 (en) | 2002-11-13 | 2003-10-31 | Diagnostics and therapeutics for diseases associated with human endothelial differentiation, lysophosphatidic acid g-protein-coupled receptor 2 (edg2) |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003278165A1 (en) |
| WO (1) | WO2004044580A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1579866A4 (en) * | 2002-12-12 | 2009-07-29 | Takeda Pharmaceutical | NEW USE OF EDG RECEPTORS |
| FR2987055A1 (en) * | 2012-02-16 | 2013-08-23 | Univ Claude Bernard Lyon | METHOD FOR DETERMINING THE ACTIVITY OF THE LPA1 LYSOPHOSPHATIDE ACID (LPA) RECEPTOR |
| ES2736045A1 (en) * | 2018-06-21 | 2019-12-23 | Univ Cadiz | METHODS FOR DIAGNOSIS AND / OR TREATMENT OF NEURODEGENERATIVE DISEASES |
| WO2024085081A1 (en) * | 2022-10-18 | 2024-04-25 | 株式会社エヌビィー健康研究所 | Antibody, nucleic acid, cell, and pharmaceutical |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997000952A2 (en) * | 1995-06-20 | 1997-01-09 | Incyte Pharmaceuticals, Inc. | A human edg-2 receptor homolog |
| US6380177B1 (en) * | 1999-06-25 | 2002-04-30 | Atairgin Technologies, Inc. | LPA analogs as agonists of the Edg2 LPA receptor |
| AU7057700A (en) * | 1999-08-18 | 2001-03-13 | Atairgin Technologies, Inc. | Compounds which modulate the activity of an lpa receptor |
| WO2002029001A2 (en) * | 2000-10-03 | 2002-04-11 | University Of Virginian Patent Foundation | Novel lysophosphatidic acid receptor agonists and antagonists |
-
2003
- 2003-10-31 AU AU2003278165A patent/AU2003278165A1/en not_active Abandoned
- 2003-10-31 WO PCT/EP2003/012121 patent/WO2004044580A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004044580A1 (en) | 2004-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003285314A1 (en) | Use of edg2 receptor in an animal model of heart failure | |
| AU2003227066A1 (en) | Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) | |
| AU2003278165A1 (en) | Diagnostics and therapeutics for diseases associated with human endothelial differentiation, lysophosphatidic acid g-protein-coupled receptor 2 (edg2) | |
| AU2003214072A1 (en) | Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) | |
| AU2002363338A1 (en) | Diagnostics and therapeutics for ocular abnormalities | |
| AU2003221527A1 (en) | Method for examining the ocular fundus | |
| AU2002352054A1 (en) | "in vitro" diagnostic method for diseases affecting human or animal tissues | |
| AU2003301991A1 (en) | Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5) | |
| AU2003210256A1 (en) | Diagnostics and therapeutics for diseases associated with endothelial differentiation lysophosphatic acid g-protein-coupled receptor 7 (edg7) | |
| AU2003287976A1 (en) | Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 3 (edg3) | |
| AU2003240720A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5) | |
| AU2003273994A1 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) | |
| AU2003296049A1 (en) | Process control based on analysis of microbial populations | |
| AU2003298111A1 (en) | Diagnostics and therapeutics for diseases associated with bile acid g-protein-coupled receptor 37 (bg37) | |
| AU2003276221A1 (en) | Diagnostics and therapeutics for diseases associated with endothelial differentiation, sphingolipid g-protein-coupled receptor 4 (edg4) | |
| AU2003229767A1 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) | |
| AU2003205627A1 (en) | Diagnostics and therapeutics for diseases associated with gpr72 | |
| AU2003267443A1 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) | |
| AU2003250128A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37) | |
| AU2003250221A1 (en) | Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 6(cxcr6) | |
| AU2003216866A1 (en) | Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) | |
| AU2003212356A1 (en) | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8) | |
| AU2003240721A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4) | |
| AU2003279361A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b) | |
| AU2003227064A1 (en) | Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |